Shingles Patients Push To Keep Zostavax MDL Alive

By P.J. D'Annunzio · October 4, 2022, 5:03 PM EDT

Patients alleging that Merck's Zostavax shingles vaccine actually caused shingles have asked a federal judge to keep their suit alive, rejecting the pharmaceutical company's position that lab tests must be provided to prove...

To view the full article, register now.

Documents

Case Information

Case Title

IN RE: ZOSTAVAX (ZOSTER VACCINE LIVE) PRODUCTS LIABILITY LITIGATION

Case Number

2:18-md-02848

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

August 02, 2018